Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 2
1995 3
1997 2
1999 3
2002 3
2003 5
2004 5
2005 6
2006 7
2007 5
2008 10
2009 8
2010 7
2011 8
2012 4
2013 11
2014 5
2015 4
2016 5
2017 2
2018 3
2019 8
2020 6
2021 6
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: bonni a. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Transcriptomic mapping uncovers Purkinje neuron plasticity driving learning.
Chen X, Du Y, Broussard GJ, Kislin M, Yuede CM, Zhang S, Dietmann S, Gabel H, Zhao G, Wang SS, Zhang X, Bonni A. Chen X, et al. Among authors: bonni a. Nature. 2022 May;605(7911):722-727. doi: 10.1038/s41586-022-04711-3. Epub 2022 May 11. Nature. 2022. PMID: 35545673 Free PMC article.
Targeting OSMR in glioma stem cells.
Mohan S, Bonni A, Jahani-Asl A. Mohan S, et al. Among authors: bonni a. Oncotarget. 2017 Mar 7;8(10):16103-16104. doi: 10.18632/oncotarget.15066. Oncotarget. 2017. PMID: 28177884 Free PMC article. No abstract available.
Cell-intrinsic drivers of dendrite morphogenesis.
Puram SV, Bonni A. Puram SV, et al. Among authors: bonni a. Development. 2013 Dec;140(23):4657-71. doi: 10.1242/dev.087676. Development. 2013. PMID: 24255095 Free PMC article. Review.
Cell intrinsic control of axon regeneration.
Mar FM, Bonni A, Sousa MM. Mar FM, et al. Among authors: bonni a. EMBO Rep. 2014 Mar;15(3):254-63. doi: 10.1002/embr.201337723. Epub 2014 Feb 14. EMBO Rep. 2014. PMID: 24531721 Free PMC article. Review.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: bonni a. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
137 results